The pseudogenes of eukaryotic translation elongation factors (EEFs): Role in cancer and other human diseases

Genes Dis. 2021 Apr 16;9(4):941-958. doi: 10.1016/j.gendis.2021.03.009. eCollection 2022 Jul.

Abstract

The eukaryotic translation elongation factors (EEFs), i.e. EEF1A1, EEF1A2, EEF1B2, EEF1D, EEF1G, EEF1E1 and EEF2, are coding-genes that play a central role in the elongation step of translation but are often altered in cancer. Less investigated are their pseudogenes. Recently, it was demonstrated that pseudogenes have a key regulatory role in the cell, especially via non-coding RNAs, and that the aberrant expression of ncRNAs has an important role in cancer development and progression. The present review paper, for the first time, collects all that published about the EEFs pseudogenes to create a base for future investigations. For most of them, the studies are in their infancy, while for others the studies suggest their involvement in normal cell physiology but also in various human diseases. However, more investigations are needed to understand their functions in both normal and cancer cells and to define which can be useful biomarkers or therapeutic targets.

Keywords: Cancer; EEFs; Non-coding RNA; Pseudogene; Translation; Translation elongation factor.

Publication types

  • Review